ARCHIVES

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

This article is from The Cancer Letter archive.

Vol. 38 No. 20 | May 18, 2012

Download PDF Visit The Full Archive

Related Articles

Amgen, J&J Defend ESA Indications.

March 21, 2008

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

FY 2000 Budget: Success Rate Drops Projected, Would Take Years to Catch Up

February 19, 1999

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981